Полина Стефански

Научные публикации

• Neurological complications following pediatric allogeneic hematopoietic stem cell transplantation: Risk factors and outcome
• SLP76 Mutation Associated with Combined Immunodeficiency and EBV-Related Lymphoma
• Vedolizumab for pediatric patients with gastrointestinal acute graft-versus-host-disease
• Incremental donor lymphocyte infusion to treat mixed chimerism after allogeneic stem cell transplantation in children with non-malignant diseases
• Two decades of stem cell transplantation in patients with Fanconi anemia: Analysis of factors affecting transplant outcomes
• Development and manufacturing of novel locally produced anti-BCMA CART cells for the treatment of relapsed/refractory multiple myeloma: phase I clinical results
• Feasibility of a Novel Academic BCMA-CART (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis
• Clinically Complex LRBA Deficiency Due to a Founder Allele in the Georgian Jewish Population
• Ibrutinib Treatment of Pediatric Chronic Graft-versus-Host Disease: Primary Results from the Phase 1/2 iMAGINE Study
• Clinical and immunophenotypic characteristics of familial leukemia predisposition caused by PAX5 germline variants
• Autoimmune Cytopenias Post Hematopoietic Stem Cell Transplantation in Pediatric Patients With Osteopetrosis and Other Nonmalignant Diseases
• GIMAP6 regulates autophagy, immune competence, and inflammation in mice and humans
• Correction to: Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients
• Lessons Learned From Five Years of Newborn Screening for Severe Combined Immunodeficiency in Israel
• Preclinical evaluation and structural optimization of anti-BCMA CAR to target multiple myeloma
• Survival of pediatric patients requiring admission in the intensive care unit post hematopoietic stem cell transplantation: Prognostic factors associated with mortality
• Neutrophil decline rate following autologous transplant for lymphoma is a predictor of patients' outcome
• Social determinants of health and primary immunodeficiency
• Clinical presentation and analysis of genotype-phenotype correlations in patients with malignant infantile osteopetrosis
• The expansion of human T-bet^highCD21^low B cells is T cell dependent
• The Clinical Aspect of Adaptor Molecules in T Cell Signaling: Lessons Learnt From Inborn Errors of Immunity
• Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients
• Evaluation of gastrointestinal symptoms in pediatric patients post hematopoietic stem cell transplantation: Ileo-colonoscopy versus sigmoidoscopy. A single-center experience and review of literature
• Toxicity and efficacy of chimeric antigen receptor T-cell therapy in patients with diffuse large B-cell lymphoma above the age of 70 years compared to younger patients - a matched control multicenter cohort study
• Characterization of a L136P mutation in Formin-like 2 (FMNL2) from a patient with chronic inflammatory bowel disease
• Eltrombopag for enhancement of platelet engraftment in patients undergoing allogeneic cord blood transplantation
• Salvage HLA-haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for graft failure in non-malignant disorders
• Genomic Spectrum and Phenotypic Heterogeneity of Human IL-21 Receptor Deficiency
• Improved transplant outcomes with myeloablative conditioning for hemophagocytic lymphohistiocytosis in HLA-matched and mismatched donors: a national multicenter retrospective study
• Alternative Splicing of the Inhibitory Immune Checkpoint Receptor SLAMF6 Generates a Dominant Positive Form, Boosting T-cell Effector Functions
• Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type I and III
• A human case of GIMAP6 deficiency: a novel primary immune deficiency
• How we approach malignant infantile osteopetrosis
• Bacillus Calmette-Guerin (BCG) Vaccine-associated Complications in Immunodeficient Patients Following Stem Cell Transplantation
• Haploidentical stem cell transplantation with post-transplant cyclophosphamide for osteopetrosis and other nonmalignant diseases
• A mutation in POLR3E impairs antiviral immune response and RNA polymerase III
• Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults
• Skeletal Changes After Hematopoietic Stem Cell Transplantation in Osteopetrosis
• Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations
• Massive osteopetrosis caused by non-functional osteoclasts in R51Q SNX10 mutant mice
• Enterococcal Bacteremia in Children With Malignancies and Following Hematopoietic Stem Cell Transplantation: A 15-Year Single-Center Experience
• Expanded circulating hematopoietic stem/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosis
• Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score
• Skin toxicity following treosulfan-thiotepa-fludarabine-based conditioning regimen in non-malignant pediatric patients undergoing hematopoietic stem cell transplantation
• The Evidence for Allogeneic Hematopoietic Stem Cell Transplantation for Congenital Neutrophil Disorders: A Comprehensive Review by the Inborn Errors Working Party Group of the EBMT
• The Broad Clinical Spectrum and Transplant Results of PNP Deficiency
• Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute Leukemia Working Party
• Successful treatment with daratumumab for post-HSCT refractory hemolytic anemia
• Gram-negative Bacteremia in Children With Hematologic Malignancies and Following Hematopoietic Stem Cell Transplantation: Epidemiology, Resistance, and Outcome
• Primary Cutaneous Clonal CD8+ T-Cell Lymphoproliferative Disorder Associated With Immunodeficiency due to RAG1 Mutation